Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia

Summary

This is a randomized, double-blind, 3-period crossover phase 2 study in patients with documented hyperuricemia to evaluate the effect of tranilast on febuxostat pharmacokinetics (PK) and pharmacodynamics (PD) and to evaluate the effect of febuxostat on tranilast PK and PD as measured by reduction in serum uric acid levels.

Timeline

Start

2009-09

Primary completion

2010-04

Completion

2010-04

Drugs

Indications